Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency

Immune responses to coronavirus disease 2019 (COVID-19) mRNA vaccines in primary antibody deficiencies (PADs) are largely unknown. We investigated antibody and CD4(+) T-cell responses specific for SARS-CoV-2 spike protein (S) before and after vaccination and associations between vaccine response and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Junghee Jenny, Par-Young, Jennefer, Unlu, Serhan, McNamara, Andrew, Park, Hong-Jai, Shin, Min Sun, Gee, Renelle J., Doyle, Hester, Afinogenova, Yuliya, Zidan, Elena, Kwah, Jason, Russo, Armand, Mamula, Mark, Hsu, Florence Ida, Catanzaro, Jason, Racke, Michael, Bucala, Richard, Wilen, Craig, Kang, Insoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203263/
https://www.ncbi.nlm.nih.gov/pubmed/35713752
http://dx.doi.org/10.1007/s10875-022-01296-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203263/
https://www.ncbi.nlm.nih.gov/pubmed/35713752
http://dx.doi.org/10.1007/s10875-022-01296-4

Ejemplares similares